WO2004002436A1 - Biliquid foam entrapment - Google Patents
Biliquid foam entrapment Download PDFInfo
- Publication number
- WO2004002436A1 WO2004002436A1 PCT/GB2003/002713 GB0302713W WO2004002436A1 WO 2004002436 A1 WO2004002436 A1 WO 2004002436A1 GB 0302713 W GB0302713 W GB 0302713W WO 2004002436 A1 WO2004002436 A1 WO 2004002436A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- powder
- biliquid foam
- dispersion
- water
- Prior art date
Links
- 239000006260 foam Substances 0.000 title claims abstract description 92
- 239000000843 powder Substances 0.000 claims abstract description 73
- 239000006185 dispersion Substances 0.000 claims abstract description 51
- 238000002360 preparation method Methods 0.000 claims abstract description 43
- 238000000034 method Methods 0.000 claims abstract description 34
- 230000008569 process Effects 0.000 claims abstract description 26
- 239000000463 material Substances 0.000 claims abstract description 24
- 239000002245 particle Substances 0.000 claims abstract description 13
- 238000001035 drying Methods 0.000 claims abstract description 10
- 239000011159 matrix material Substances 0.000 claims abstract description 8
- 239000007900 aqueous suspension Substances 0.000 claims abstract description 6
- 239000007864 aqueous solution Substances 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 95
- 239000003921 oil Substances 0.000 claims description 79
- 235000019198 oils Nutrition 0.000 claims description 79
- 229920000642 polymer Polymers 0.000 claims description 50
- 239000012071 phase Substances 0.000 claims description 45
- 239000008346 aqueous phase Substances 0.000 claims description 30
- 238000001694 spray drying Methods 0.000 claims description 29
- 239000000203 mixture Substances 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 14
- 244000215068 Acacia senegal Species 0.000 claims description 10
- 229920000084 Gum arabic Polymers 0.000 claims description 10
- 229920000881 Modified starch Polymers 0.000 claims description 10
- 235000010489 acacia gum Nutrition 0.000 claims description 10
- 230000015572 biosynthetic process Effects 0.000 claims description 10
- 239000003205 fragrance Substances 0.000 claims description 10
- -1 lanolate Chemical compound 0.000 claims description 10
- 230000001877 deodorizing effect Effects 0.000 claims description 8
- 235000019426 modified starch Nutrition 0.000 claims description 8
- 235000006491 Acacia senegal Nutrition 0.000 claims description 7
- 239000004368 Modified starch Substances 0.000 claims description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 229940008099 dimethicone Drugs 0.000 claims description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 6
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 claims description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 6
- 239000002243 precursor Substances 0.000 claims description 6
- 235000019502 Orange oil Nutrition 0.000 claims description 5
- 238000005469 granulation Methods 0.000 claims description 5
- 230000003179 granulation Effects 0.000 claims description 5
- 235000010446 mineral oil Nutrition 0.000 claims description 5
- 239000002480 mineral oil Substances 0.000 claims description 5
- 239000010502 orange oil Substances 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 108010010803 Gelatin Proteins 0.000 claims description 4
- 238000004090 dissolution Methods 0.000 claims description 4
- 229920000159 gelatin Polymers 0.000 claims description 4
- 239000008273 gelatin Substances 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 4
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 229920002148 Gellan gum Polymers 0.000 claims description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 3
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 claims description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 3
- 206010021639 Incontinence Diseases 0.000 claims description 3
- 239000004166 Lanolin Substances 0.000 claims description 3
- 239000004952 Polyamide Substances 0.000 claims description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 3
- 229920001800 Shellac Polymers 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 235000019486 Sunflower oil Nutrition 0.000 claims description 3
- 239000000205 acacia gum Substances 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 235000021302 avocado oil Nutrition 0.000 claims description 3
- 239000008163 avocado oil Substances 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- 239000003240 coconut oil Substances 0.000 claims description 3
- 235000019864 coconut oil Nutrition 0.000 claims description 3
- 229940086555 cyclomethicone Drugs 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 235000010492 gellan gum Nutrition 0.000 claims description 3
- 239000000216 gellan gum Substances 0.000 claims description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 claims description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 3
- 229940093629 isopropyl isostearate Drugs 0.000 claims description 3
- 235000019388 lanolin Nutrition 0.000 claims description 3
- 229940039717 lanolin Drugs 0.000 claims description 3
- 229920000609 methyl cellulose Polymers 0.000 claims description 3
- 239000001923 methylcellulose Substances 0.000 claims description 3
- 235000010981 methylcellulose Nutrition 0.000 claims description 3
- 229940105132 myristate Drugs 0.000 claims description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 3
- 229940055577 oleyl alcohol Drugs 0.000 claims description 3
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 claims description 3
- 229940057874 phenyl trimethicone Drugs 0.000 claims description 3
- 229920002647 polyamide Polymers 0.000 claims description 3
- 229920002689 polyvinyl acetate Polymers 0.000 claims description 3
- 239000011118 polyvinyl acetate Substances 0.000 claims description 3
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 claims description 3
- 235000013874 shellac Nutrition 0.000 claims description 3
- 239000004208 shellac Substances 0.000 claims description 3
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 claims description 3
- 229940113147 shellac Drugs 0.000 claims description 3
- 239000003549 soybean oil Substances 0.000 claims description 3
- 235000012424 soybean oil Nutrition 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000002600 sunflower oil Substances 0.000 claims description 3
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims description 3
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 3
- UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 claims description 3
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 2
- 229940072056 alginate Drugs 0.000 claims 2
- 239000008107 starch Substances 0.000 claims 2
- 239000000230 xanthan gum Substances 0.000 claims 2
- 235000010493 xanthan gum Nutrition 0.000 claims 2
- 229940082509 xanthan gum Drugs 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 1
- 238000003756 stirring Methods 0.000 description 38
- 239000004615 ingredient Substances 0.000 description 31
- 239000003094 microcapsule Substances 0.000 description 15
- 229920002774 Maltodextrin Polymers 0.000 description 13
- 239000005913 Maltodextrin Substances 0.000 description 13
- 229940035034 maltodextrin Drugs 0.000 description 13
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 10
- 239000002304 perfume Substances 0.000 description 9
- 239000004094 surface-active agent Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 229910021653 sulphate ion Inorganic materials 0.000 description 7
- 229920001213 Polysorbate 20 Polymers 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 6
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 6
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 5
- 239000004359 castor oil Substances 0.000 description 5
- 235000019438 castor oil Nutrition 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- KWVPFECTOKLOBL-KTKRTIGZSA-N 2-[(z)-octadec-9-enoxy]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCO KWVPFECTOKLOBL-KTKRTIGZSA-N 0.000 description 4
- IEXKUCOGQITOPO-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEXKUCOGQITOPO-UHFFFAOYSA-N 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- FKMHSNTVILORFA-UHFFFAOYSA-N 2-[2-(2-dodecoxyethoxy)ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCO FKMHSNTVILORFA-UHFFFAOYSA-N 0.000 description 2
- 229920002245 Dextrose equivalent Polymers 0.000 description 2
- 229920004511 Dow Corning® 200 Fluid Polymers 0.000 description 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 229920003081 Povidone K 30 Polymers 0.000 description 2
- 229920003180 amino resin Polymers 0.000 description 2
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000001311 chemical methods and process Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- FCZCIXQGZOUIDN-UHFFFAOYSA-N ethyl 2-diethoxyphosphinothioyloxyacetate Chemical compound CCOC(=O)COP(=S)(OCC)OCC FCZCIXQGZOUIDN-UHFFFAOYSA-N 0.000 description 2
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 2
- 229960001680 ibuprofen Drugs 0.000 description 2
- 229940057905 laureth-3 Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- JPMIIZHYYWMHDT-UHFFFAOYSA-N octhilinone Chemical compound CCCCCCCCN1SC=CC1=O JPMIIZHYYWMHDT-UHFFFAOYSA-N 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- XUJLWPFSUCHPQL-UHFFFAOYSA-N 11-methyldodecan-1-ol Chemical class CC(C)CCCCCCCCCCO XUJLWPFSUCHPQL-UHFFFAOYSA-N 0.000 description 1
- XOEUNIAGBKGZLU-UHFFFAOYSA-N 3,3-bis(2-methyl-1-octylindol-3-yl)-2-benzofuran-1-one Chemical compound C1=CC=C2C(C3(C4=CC=CC=C4C(=O)O3)C3=C(C)N(C4=CC=CC=C43)CCCCCCCC)=C(C)N(CCCCCCCC)C2=C1 XOEUNIAGBKGZLU-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002884 Laureth 4 Polymers 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- IZWSFJTYBVKZNK-UHFFFAOYSA-O N-dodecyl-N,N-dimethyl-3-ammonio-1-propanesulfonic acid Chemical compound CCCCCCCCCCCC[N+](C)(C)CCCS(O)(=O)=O IZWSFJTYBVKZNK-UHFFFAOYSA-O 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000005599 alkyl carboxylate group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000000222 aromatherapy Methods 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 238000005354 coacervation Methods 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- IVJISJACKSSFGE-UHFFFAOYSA-N formaldehyde;1,3,5-triazine-2,4,6-triamine Chemical compound O=C.NC1=NC(N)=NC(N)=N1 IVJISJACKSSFGE-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- PYGSKMBEVAICCR-UHFFFAOYSA-N hexa-1,5-diene Chemical group C=CCCC=C PYGSKMBEVAICCR-UHFFFAOYSA-N 0.000 description 1
- 239000007970 homogeneous dispersion Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940100556 laureth-23 Drugs 0.000 description 1
- 229940061515 laureth-4 Drugs 0.000 description 1
- 231100001225 mammalian toxicity Toxicity 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- ODGAOXROABLFNM-UHFFFAOYSA-N polynoxylin Chemical compound O=C.NC(N)=O ODGAOXROABLFNM-UHFFFAOYSA-N 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000008262 pumice Substances 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000003763 resistance to breakage Effects 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/0039—Coated compositions or coated components in the compositions, (micro)capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q13/00—Formulations or additives for perfume preparations
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D11/00—Special methods for preparing compositions containing mixtures of detergents
- C11D11/0082—Special methods for preparing compositions containing mixtures of detergents one or more of the detergent ingredients being in a liquefied state, e.g. slurry, paste or melt, and the process resulting in solid detergent particles such as granules, powders or beads
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/04—Detergent materials or soaps characterised by their shape or physical properties combined with or containing other objects
- C11D17/049—Cleaning or scouring pads; Wipes
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/06—Powder; Flakes; Free-flowing mixtures; Sheets
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/50—Perfumes
- C11D3/502—Protected perfumes
- C11D3/505—Protected perfumes encapsulated or adsorbed on a carrier, e.g. zeolite or clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D2111/00—Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
- C11D2111/10—Objects to be cleaned
- C11D2111/14—Hard surfaces
Definitions
- the present invention relates to biliquid foam entrapment and, in particular, to a biliquid foam entrapped within a matrix of a polymeric material which is in the form of a discrete powder.
- oils or oil soluble substances especially perfumes and coloured dye precursors
- Microcapsules of this type comprise individual droplets of oil or oil soluble substances (of size ranging from sub-micrometre to tens of millimetres in diameter) around which polymer walls have been formed by one of a number of chemical processes.
- Such microcapsules are prepared as an aqueous suspension which is then capable, with the addition of suitable modifying reagents, of being sprayed or printed onto paper and other surfaces.
- suitable modifying reagents for example, perfumes
- oil soluble species for example, colourless dye precursors
- Such coatings find major uses, for example, in the forms of "scratch and sniff" perfume coatings or NCR (No Carbon Required) paper.
- these microcapsules suffer from a number of disadvantages.
- microcapsules are formed in a lengthy and uncertain one in which control over temperature, pH and the absence of any form of contamination is essential.
- the formation of microcapsules for example, by complex coacervation from gelatin and an anionic complexing species such as gum acacia takes many hours and demands very close control of pH, temperature and cooling rate.
- the formation of microcapsule walls from aminoplast resins, such as melamine-formaldehyde or urea-formaldehyde takes at least eight hours during which precise control over all controllable parameters needs to be effected.
- the effectiveness and completeness of any individual encapsulation process depends largely on the chemical nature of the oil and/or oil soluble substances being encapsulated.
- microcapsulation A further disadvantage of microcapsulation is that the thickness and therefore the strength of the microcapsule wall is variable and is not easily controllable and varies with the nature of the oil or oil-soluble substances being encapsulated. Thus microcapsules made by the same process but from different oils may have widely differing strengths and resistance to breakage during the printing process and during subsequent storage and use.
- a yet further disadvantage of microencapsulation is the limited number of chemical processes and the limited number and type of polymeric wall materials which are available to form them.
- the choice as to the properties of the wall materials is consequently limited with regard to their flexibility, tensile strength, permeability, chemical inertness, mammalian toxicity and other properties including solubility and melting point (if any) .
- some of the chemicals commonly used in the wall forming process are themselves highly irritating and may themselves be toxic such, for example, as the use or release of formaldehyde (a potential carcinogen) during the manufacture of aminoplast resin walls.
- formaldehyde a potential carcinogen
- microcapsules Whilst many of the processes to produce microcapsules produce dispersions of the microcapsules in a fluid medium, they can also be produced in the form of a powder.
- EP-B-0938932 discloses a process for manufacturing a cosmetic and/or dermatological powder in which an oil-in-water dispersion comprising at least one modified starch is dehydrated to form a powder
- US-A-6129906 in which a granular powder is formed by spray drying an aqueous dispersion of a silicone oil and a water-soluble carrier, the silicone oil being present in the dispersion as discrete droplets having a droplet size in the range of from 0.5 ⁇ m to 20 ⁇ m.
- WO 99/05299 discloses a surface coating in which droplets of a non-polar substance are trapped within a polymer film, the surface coating being prepared by drying a dispersion of a film forming polymer containing droplets of a suspended biliquid foam or emulsion. Surface coatings only are disclosed and this reference does not teach the drying of the dispersions to form a powder.
- a discrete powder which is based upon the encapsulation of a biliquid foam. Accordingly, in one aspect of the present invention provides a discrete powder which comprises particles in which a biliquid foam has been entrapped within a matrix of a polymeric material.
- the present invention provides a process for the preparation of a discrete powder which comprises a biliquid foam entrapped within a matrix of a polymeric material, which process comprises the steps of: i) preparing a biliquid foam, ii) forming a dispersion of the biliquid foam in an aqueous solution, suspension or dispersion of a polymeric material, and iii) subjecting the dispersion to drying under conditions such that a discrete powder is formed.
- the discrete powder of the present invention is preferably produced by spray drying of the dispersion.
- Biliquid foams are known in the art and are described in the following literature references by Sebba: "Biliquid foams", J. Colloid and Interface Science, 40 (1972) 468-474; and "The Behaviour of Minute Oil Droplets Encapsulated in a Water Film",
- the oil-based biliquid foam used in the spray dried powders of the present invention will preferably comprise from 70 to 95% by weight of the oil phase and from 5 to 30% by weight of the continuous phase.
- a surfactant to stabilise the biliquid foam may also be included in an amount of from 0.01 to 3%, preferably from 0.1 to 1% based on the total weight of the biliquid foam.
- the surfactant may dissolve in either the oil phase, the continuous phase or both phases of the biliquid foam.
- the level of surfactant used in the formation of the biliquid foams is lower than the level used in the preparation of conventional dry emulsion systems.
- Oils which may be used in the biliquid foam will in general be substantially water immiscible and liquid at room temperature and may be, for example, a cyclomethicone, dimethicone, phenyl trimethicone, dimethiconol, dimethicone copolyol, trimethylsiloxy- silicate, an emollient ester such as isopropyl isostearate, lanolate, myristate or palmitate, or octyl palmitate, a glyceride such as avocado oil, coconut oil, soybean oil or sunflower oil, or a caprylic/capric triglyceride, a lanolin oil, orange oil, mineral oil or natural oil, or oleyl alcohol, or any other oil generally known for this purpose, or mixtures of the foregoing.
- a glyceride such as avocado oil, coconut oil, soybean oil or sunflower oil, or a caprylic/capric triglyceride, a lanolin oil,
- the present invention enables oils to be incorporated into the powder which would normally be difficult to incorporate into conventional dry emulsion systems.
- the oil phase of the biliquid foam may contain or consist of one or more active ingredients such as fragrances, flavours, deodorisers, perfumes, pharmaceuticals, sunscreens, dyes, pesticides, insect repellants, herbicides, etc.
- the biliquid foam may contain, as described above, a low level of a surfactant which may be, for example: - a cationic surfactant such as an amidoamine, a quaternary ammonium compound or a sulphonium salt; an amphoteric surfactant such as an acylamino- acid, an N-substituted alkylamine, an N-alkyl- ⁇ -amino- propionate, an N-alkylbetaine, an alkylimidazoline or a sulphobetaine; an anionic surfactant such as an acyl-lactate, N- acylsarcosinate, alkyl-carboxylate (either mono- or polyvalent) , alkyl ether carboxylate, N-alkyl- glutamate, fatty acid-peptide condensate, phosphated ethoxylated alcohol, alkyl sulphate, ethoxylated alkyl sulphate, alpha-
- the continuous phase of the biliquid foam is generally an aqueous phase which may include therein a substantial level of a Cj-C,, (water miscible) alcohol, or ethylene glycol or mixtures thereof.
- the continuous phase of the biliquid foam may include therein preservatives, stabilizers or other materials known in the art.
- Methods of producing biliquid foams are described in US-A-4486333 involving the preliminary formation of a gas foam in order to provide a sufficiently large surface area on which the biliquid foam can subsequently be formed. It has been found that the prior formation of a gas foam is not required to manufacture a stable biliquid foam, provided that a suitable stirring mechanism is provided in the manufacturing vessel.
- An aspect of the present invention is the ability to manufacture biliquid foams without the preliminary formation of gas foam, by the use of a tank incorporating a suitable stirring mechanism.
- Such an apparatus comprises a tank provided with a stirrer in which the stirrer blade breaks the interface between the liquid and air.
- a delivery device is provided through which the oil phase (water immiscible liquid) , which will comprise the internal phase of the dispersion, is delivered to the tank.
- the design of the delivery device is such that the rate of addition of the internal phase fluid can be controlled and varied during the production process.
- a feature of the production process is that the internal (oil) phase is added to the stirred aqueous phase slowly at first until sufficient droplets have been formed to constitute a large, additional surface area for the more rapid formation of new droplets. At this point, the rate of addition of the oil phase may be increased.
- the production process consists of the following steps :
- the stirring rate and the rate of addition of the oil phase are variables, the values of which depend upon the detailed design of the manufacturing plant (in particular, the ratio of tank diameter to impeller diameter) , the physico-chemical properties of the oil phase and the nature and concentrations of the chosen surfactants. These can all be pre-determined by laboratory or pilot plant experiment.
- the biliquid foam is entrapped within a polymeric material and thereby forms a discrete powder.
- Water-dispersible or water- soluble film forming polymers of many types are well known and include cellulose derivatives (for example, carboxymethylcellulose, hydroxyethylcellulose, cetylhydroxycellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylmethyl- cellulose and methylcellulose) , gelatin, gum arabic, gum acacia, gellan gum, shellac, carragenan, natural starches, modified starches, xanthan gums, alginates, dextrins, polyvinyl alcohol, polyvinyl acetate, polyvinyl pyrollidone or polyamides and other water dispersible or water soluble film forming agents known in the art.
- the present invention may include the use of all the above singly or in combination. Certain of the polymers may only be water-dispersible or water- soluble at elevated temperatures and therefore in the preparation of the dispersions of the biliquid foams and during spray drying, the dispersion mixture would be used at these elevated temperatures. Industrial, food or pharmaceutical grade polymers may be used, depending upon the end use of the dried powder.
- suspension of the biliquid foam in an aqueous solution suspension or dispersion of the polymeric film former is dried under conditions such that a discrete powder is formed.
- the said dispersion is spray dried.
- the choice of suitable spray drying conditions will be within the knowledge of a person skilled in the art and will depend upon various factors, including the melt temperature of the polymeric material, the amount of water contained in the dispersion, the ratio of polymeric material to the biliquid foam etc.
- the inlet temperature for the spray dryer will be in the range of from 170° to 210°C and the outlet temperature will be in the range of from 85 to 110°C.
- the dispersion which is subjected to drying may also incorporate a structuring or gelling agent therein. Any such agent must, however, shear thin when the dispersion is subjected to atomisation forces, for example during spray drying. Such a structuring or gelling agent may assist in maintaining the integrity of the dispersion prior to the drying process .
- the biliquid foam will have a mean droplet size in the range of from 1 to 45 micrometres.
- a biliquid foam having such a droplet size can generally be produced under low shear conditions.
- the droplet size of the majority of the droplets of the biliquid foam should preferably be further reduced to below 12 micrometres, for example by using higher shear conditions.
- the biliquid foam is then mixed with an aqueous solution, suspension or dispersion of the polymeric material under conditions which generate a homogeneous dispersion. For example, using gentle stirring or using a high shear device, such as a Roto Stator mixer.
- a high shear device such as a Roto Stator mixer.
- spray drying is the preferred method of producing the discrete powders of the present invention, other drying techniques, such as freeze drying and fluidized bed granulation can also be used.
- the discrete powders of the present invention generally incorporate high levels of oil entrapped within the polymeric material, typically from 5 to 50% by weight, preferably from 20 to 40% by weight based on the weight of the powder.
- the discrete powders of the present invention will generally have a mean particle size in the range of from 5 to 150 ⁇ m. It will be understood, however, that larger particle sizes may be obtained by the use of techniques known in the art, such as granulation. The size range may then be of the order of 5 ⁇ m to 1mm.
- the invention provides a means of controlling the rate of release of the oil entrapped within the polymeric material by exercising control over the concentration and ratio to the biliquid foam of the film forming polymer in solution or suspension and thereby controlling the thickness and strength of the film forming the outside of the particles.
- the invention also allows for release of the oil by dissolution of the film by contact with water or other polar solvent.
- the powder may contain a fragrance or aromatherapy oil and be sprinkled onto water in a bath.
- the water-soluble or water dispersible film forming polymer may be partially or wholly crosslinked to render it partially or totally water insoluble by which means the rate of release of the entrapped biliquid foam may be controlled by the speed or absence of dissolution when the powder makes contact with water or other polar liquid in which it might otherwise be soluble. Different powders could then be mixed together in order to give a range of release rates, if required.
- the choice of film-forming polymer may be such that it is sensitive to acidity or alkalinity so that the release of the entrapped oil may be determined by a change of pH or by the presence of another chemical species with which the film- forming polymers may react, so rendering it permeable or unstable.
- the choice of film- forming polymer may be such that it is sensitive to temperature or biological conditions.
- the powder may alternatively comprise a polymer which melts at a known and predetermined temperature to release the entrapped oil.
- the entrapped biliquid foam may comprise a perfume which, when dried into a discrete powder will behave and perform precisely as a conventional, microencapsulated "scratch and sniff" perfume as previously described.
- an encapsulating polymer may be chosen that allows the release of the perfume by diffusion over time, such as in a room fragrancing device.
- a perfume or deodorising composition is entrapped according to this invention in a discrete powder which is incorporated into a diaper, incontinence pad or feminine hygiene product during manufacture so that the perfume or deodorising composition is released on contact with aqueous bodily fluids when the diaper, incontinence pad or feminine hygiene product is used, thereby masking or neutralising any disagreeable odour.
- the powder may be provided as a dry skin wash composition containing a cleansing, moisturising or emollient oil.
- the dry powder would be applied to the skin and rubbed either with or without the addition of water in order to release the entrapped from the polymer matrix.
- the biliquid foam comprising a household cleaning oil, such as orange oil may be entrapped in water soluble polymer powder particles on a suitable applicator together with other reagents (for example, an abrasive material, such as a pumice or water soluble antimicrobial agents) to form a dry surface which, when wetted, becomes an effective hard surface cleaning product.
- the powder may be provided as a carpet or fabric cleaning or deodorizing composition and the oil will then comprise a suitable cleaning or deodorizing oil.
- the matrix forming polymer may comprise a brittle film which ruptures easily when deformed so releasing the entrapped non- polar substance.
- the powder may be coated onto a flexible film which may, for example, be shrunk onto the cap of a consumer product such that if the flexible film is removed, the particles rupture so releasing the non- polar substance which, in this instance, may be the colourless precursor of a coloured dye which, on release, undergoes a chemical change to become highly coloured. This embodiment thereby gives a clear indication as to whether or not a closure has been tampered with.
- the powder may be incorporated into the film forming polymer precursor during the preparation of the flexible films.
- the film forming polymer precursor will be chosen from suitable materials which do not dissolve the powder.
- the discrete powder particles may be granulated or formed into tablets according to techniques known in the art. In these processes the powder may be combined with one or more binders, excipients, fillers, disintegrants or other suitable materials .
- the powders of the present invention may also be incorporated during extrusion of a polymer melt.
- the polymer system will be selected such that the polymer melt does not dissolve the polymer used in the preparation of the powders of the invention.
- the melt temperature of the polymer used in forming the powders will also need to be greater than that of the extruding polymer.
- the oil which is incorporated into the powder may be chosen such that it boils at a given temperature, thereby rupturing the powder, or film or extruded polymer containing the powder, thereby causing a trigger release of the oil.
- This embodiment may be used, for example, for the release of a latent catalyst which may enable controlled chemical modification of the extruding polymer to take place.
- a still further release mechanism may be the use of polymeric systems in the formation of the powders of the invention which are biodegradable, thermally degradable or photodegradable. The oil contained in the powders would then be released on degradation of the polymers.
- a biliquid foam was prepared from the following ingredients .
- the biliquid foam was prepared by adding the oil phase to the aqueous phase and stirring with a flat bladed stirrer at 300 rpm until the mean droplet size was 15-20 micrometres.
- the biliquid foam was prepared by adding the oil phase to the aqueous phase and stirring with a flat bladed stirrer at 116 rpm.
- the mean droplet diameter was 35 micrometres.
- the stirrer speed was then increased to 250 rpm and stirred until the mean droplet size was less than 12 micrometres.
- the biliquid foam was prepared by adding the oil phase to the aqueous phase whilst stirring with a flat bladed stirrer at 200 rpm for 45 minutes.
- the biliquid foam was prepared by adding the oil phase to the aqueous phase whilst stirring with a flat bladed stirrer at 200 rpm for 45 minutes.
- the biliquid foam was prepared by adding the oil phase to the aqueous phase whilst stirring with a flat bladed stirrer at 200 rpm for 45 minutes.
- the biliquid foam was prepared by adding the oil phase to the aqueous phase whilst stirring with a flat bladed stirrer at 200 rpm for 45 minutes.
- the biliquid foam was prepared by adding the oil phase to the aqueous phase whilst stirring with a flat bladed stirrer at 200 rpm for 45 minutes.
- the biliquid foam was prepared by adding the oil phase to the aqueous phase and stirring with a flat bladed stirrer at 174 rpm.
- the stirrer speed was increased to 300 rpm to help with the inclusion of the oil before continuing to stir at 174 rpm until the mean droplet size was 11 ⁇ m.
- the biliquid foam was prepared by adding the oil phase (ibuprofen fully dissolved in the isopropyl myristate) to the aqueous phase and stirring with a - I f
- the biliquid foam was prepared by adding the oil phase to the aqueous phase whilst stirring with a flat bladed stirrer at 220 rpm for 60 minutes. The procedure was repeated twice more to generate three 500g batches which were blended together for use in spray drying examples.
- the biliquid foam was prepared by adding the oil phase to the aqueous phase whilst stirring with a flat bladed stirrer at 110 rpm for 30 minutes. The preparation was then sheared at 230 rpm until the droplet size was less than 10 microns.
- the biliquid foam was prepared by adding the oil phase to the aqueous phase whilst stirring with a flat bladed stirrer at 180 rpm for 60 minutes. The preparation was stirred at 230 rpm until the droplet size was less than 10 microns.
- Emulsifier A consists of:
- the dispersion was prepared by stirring the biliquid foam into the aqueous polymer immediately before spray drying.
- the dispersion was prepared by stirring the biliquid foam into the aqueous polymer immediately before spray drying.
- the dispersion was prepared by stirring the biliquid foam and water into the aqueous polymer immediately before spray drying.
- the dispersion was prepared by stirring the biliquid foam and make up water into the aqueous polymer immediately before spray drying.
- PVP K30 (30% by weight 816.67 81.67 in demineralized water)
- the dispersion was prepared by stirring the biliquid foam and water into the aqueous polymers immediately before spray drying.
- the dispersion was prepared by stirring the biliquid foam and water into the aqueous polymers immediately before spray drying.
- the dispersion was prepared by stirring the biliquid foam and water into the aqueous polymers immediately before spray drying.
- the dispersion was prepared by stirring the biliquid foam and water into the aqueous polymers immediately before spray drying.
- the dispersion was prepared by stirring the biliquid foam and water into the aqueous polymer immediately before spray drying.
- the dispersion was prepared by stirring the biliquid foam and water into the aqueous polymers immediately before spray drying.
- the dispersion was prepared by stirring the biliquid foam and water into the aqueous polymers immediately before spray drying.
- the dispersion was prepared by stirring the biliquid foam and water into the aqueous polymers immediately before spray drying.
- the dispersion was prepared by stirring the biliquid foam and water into the aqueous polymers immediately before spray drying.
- the dispersion was prepared by stirring the biliquid foam and water into the aqueous polymers immediately before spray drying.
- the dispersion was prepared by stirring the biliquid foam and water into the aqueous polymers immediately before spray drying.
- Preparation 10 175.00 17.5 PVP k30 (40% by 433.12 43.31 weight in demineralized water) Water 343.75 38.38
- the dispersion was prepared by stirring the biliquid foam and water into the aqueous polymers immediately before spray drying.
- the dispersion was prepared by stirring the biliquid foam and water into the aqueous polymers immediately before spray drying.
- the dispersion was prepared by stirring the biliquid foam and water into the aqueous polymers immediately before spray drying. The dispersion was sheared for 2 minutes on a Silverson disperser before spraying to ensure good mixing.
- Modified starch is a chemically modified food starch with a dextrose equivalent value of 32-37%.
- the dispersion was prepared by stirring the biliquid foam and water into the aqueous polymers immediately before spray drying. The dispersion was sheared for 2 minutes on a Silverson disperser before spraying to ensure good mixing.
- Modified starch is a chemically modified food starch with a dextrose equivalent value of 32-37%
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dispersion Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003236910A AU2003236910B2 (en) | 2002-06-26 | 2003-06-24 | Biliquid foam entrapment. |
JP2004516925A JP4733387B2 (en) | 2002-06-26 | 2003-06-24 | Containment of two liquid bubbles |
DE60308519T DE60308519T2 (en) | 2002-06-26 | 2003-06-24 | INCLUDING A SHOW OF TWO LIQUIDS |
EP03735830A EP1515682B1 (en) | 2002-06-26 | 2003-06-24 | Biliquid foam entrapment |
US10/517,208 US8034325B2 (en) | 2002-06-26 | 2003-06-24 | Powder formed of particles of biliquid foam entrapped within polymeric matrix |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0214793.2A GB0214793D0 (en) | 2002-06-26 | 2002-06-26 | Biliquid foam entrapment |
GB0214793.2 | 2002-06-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004002436A1 true WO2004002436A1 (en) | 2004-01-08 |
Family
ID=9939349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2003/002713 WO2004002436A1 (en) | 2002-06-26 | 2003-06-24 | Biliquid foam entrapment |
Country Status (8)
Country | Link |
---|---|
US (1) | US8034325B2 (en) |
EP (1) | EP1515682B1 (en) |
JP (1) | JP4733387B2 (en) |
CN (1) | CN1703186A (en) |
AU (1) | AU2003236910B2 (en) |
DE (1) | DE60308519T2 (en) |
GB (1) | GB0214793D0 (en) |
WO (1) | WO2004002436A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005011643A1 (en) * | 2003-07-30 | 2005-02-10 | Drug Delivery Solutions Limited | Biliquid foams, stable dispersions thereof and a corresponding process of manufacturing |
WO2005070379A1 (en) * | 2004-01-19 | 2005-08-04 | Disperse Limited | Dispersions |
JP2006035036A (en) * | 2004-07-23 | 2006-02-09 | Kao Corp | Oily chemical-containing particle |
WO2009001099A2 (en) | 2007-06-26 | 2008-12-31 | Drug Delivery Solutions Limited | A pharmaceutical composition |
CN108530939A (en) * | 2018-04-18 | 2018-09-14 | 济南大学 | A kind of foam spray drying method prepares Determination of Astaxanthin in Haematococcus Pluvialis microcapsules and preparation method thereof |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0317869D0 (en) * | 2003-07-30 | 2003-09-03 | Disperse Ltd | Improved drug delivery system |
EP1591131B1 (en) * | 2004-04-30 | 2011-06-15 | The Procter & Gamble Company | Colour-changing absorbent article |
US10265265B2 (en) | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
EP2008651A1 (en) | 2007-06-26 | 2008-12-31 | Drug Delivery Solutions Limited | A bioerodible patch |
KR100869371B1 (en) | 2007-09-10 | 2008-11-24 | 황치화 | Method for reducing volume of wasted expanded polystyrene |
CN108273065B (en) | 2011-03-14 | 2020-07-31 | 药品配送方案有限公司 | Ophthalmic composition |
JP2015168654A (en) * | 2014-03-07 | 2015-09-28 | 三笠製薬株式会社 | Aqueous composition for nsaids containing foaming formulation |
EP3542788A1 (en) | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Topical composition comprising calcipotriol and betamethasone dipropionate |
US11990734B2 (en) * | 2021-10-12 | 2024-05-21 | Eaton Intelligent Power Limited | Cable gland for armored cable |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH664372A5 (en) * | 1984-03-02 | 1988-02-29 | Vorwerk Co Interholding | Low free-formaldehyde urea]-formaldehyde] form |
US4986429A (en) * | 1989-06-12 | 1991-01-22 | Singleton Jr Robert | Color indicating tamper-proof seal |
US6165479A (en) * | 1996-03-08 | 2000-12-26 | Disperse Technologies Limited | Dispersions comprising an oil-based biliquid foam and an aqueous gel |
WO2001062214A1 (en) * | 2000-02-22 | 2001-08-30 | Color Access, Inc. | Gelled aqueous cosmetic compositions |
US6312760B1 (en) * | 1997-07-22 | 2001-11-06 | Disperse Limited | Surface coatings |
DE10107217A1 (en) * | 2000-05-17 | 2001-11-22 | Henkel Kgaa | Solid water-soluble polymeric foams use as detergent or cleaning articles, containing builders, acidifiers, chelate complex-formers, deposition-inhibiting polymers and/or nonionic surfactants |
US6358493B1 (en) * | 1999-06-09 | 2002-03-19 | Wella Aktiengesellschaft | Methods of performing cosmetic treatments with gasified solid particles and instant gel preparations containing the gasified solid particles |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3016308A (en) * | 1957-08-06 | 1962-01-09 | Moore Business Forms Inc | Recording paper coated with microscopic capsules of coloring material, capsules and method of making |
US3549555A (en) * | 1968-10-08 | 1970-12-22 | Ncr Co | Encapsulation of lipophilic liquid-in-hydrophilic liquid emulsions |
US4486333A (en) * | 1981-04-10 | 1984-12-04 | Felix Sebba | Preparation of biliquid foam compositions |
US4999198A (en) * | 1989-03-23 | 1991-03-12 | The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations | Polyaphrons as a drug delivery system |
FR2774284B1 (en) * | 1998-02-03 | 2001-06-29 | Oreal | COSMETIC AND / OR DERMATOLOGICAL POWDER, PREPARATION METHOD THEREOF AND USES THEREOF |
CA2471388A1 (en) * | 2001-12-21 | 2003-07-10 | Herman Jan Tijmen Coelingh Bennink | Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
-
2002
- 2002-06-26 GB GBGB0214793.2A patent/GB0214793D0/en not_active Ceased
-
2003
- 2003-06-24 EP EP03735830A patent/EP1515682B1/en not_active Expired - Fee Related
- 2003-06-24 US US10/517,208 patent/US8034325B2/en not_active Expired - Fee Related
- 2003-06-24 CN CN03814837.4A patent/CN1703186A/en active Pending
- 2003-06-24 JP JP2004516925A patent/JP4733387B2/en not_active Expired - Fee Related
- 2003-06-24 WO PCT/GB2003/002713 patent/WO2004002436A1/en active IP Right Grant
- 2003-06-24 DE DE60308519T patent/DE60308519T2/en not_active Expired - Lifetime
- 2003-06-24 AU AU2003236910A patent/AU2003236910B2/en not_active Ceased
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH664372A5 (en) * | 1984-03-02 | 1988-02-29 | Vorwerk Co Interholding | Low free-formaldehyde urea]-formaldehyde] form |
US4986429A (en) * | 1989-06-12 | 1991-01-22 | Singleton Jr Robert | Color indicating tamper-proof seal |
US6165479A (en) * | 1996-03-08 | 2000-12-26 | Disperse Technologies Limited | Dispersions comprising an oil-based biliquid foam and an aqueous gel |
US6312760B1 (en) * | 1997-07-22 | 2001-11-06 | Disperse Limited | Surface coatings |
US6358493B1 (en) * | 1999-06-09 | 2002-03-19 | Wella Aktiengesellschaft | Methods of performing cosmetic treatments with gasified solid particles and instant gel preparations containing the gasified solid particles |
WO2001062214A1 (en) * | 2000-02-22 | 2001-08-30 | Color Access, Inc. | Gelled aqueous cosmetic compositions |
DE10107217A1 (en) * | 2000-05-17 | 2001-11-22 | Henkel Kgaa | Solid water-soluble polymeric foams use as detergent or cleaning articles, containing builders, acidifiers, chelate complex-formers, deposition-inhibiting polymers and/or nonionic surfactants |
Non-Patent Citations (1)
Title |
---|
DISPERSE TECHNOLOGIES PLC: "For Release: Placing and Offer for Subscription", INTERNET ARTICLE, 19 March 2002 (2002-03-19), pages 1 - 18, XP002256459, Retrieved from the Internet <URL:www.disperseplc.com/archive/19-03-2002.PDF> [retrieved on 20031001] * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005011643A1 (en) * | 2003-07-30 | 2005-02-10 | Drug Delivery Solutions Limited | Biliquid foams, stable dispersions thereof and a corresponding process of manufacturing |
WO2005070379A1 (en) * | 2004-01-19 | 2005-08-04 | Disperse Limited | Dispersions |
US7709431B2 (en) | 2004-01-19 | 2010-05-04 | Disperse Limited | Solid dispersions comprising aphrons |
JP2006035036A (en) * | 2004-07-23 | 2006-02-09 | Kao Corp | Oily chemical-containing particle |
WO2009001099A2 (en) | 2007-06-26 | 2008-12-31 | Drug Delivery Solutions Limited | A pharmaceutical composition |
WO2009001099A3 (en) * | 2007-06-26 | 2009-11-12 | Drug Delivery Solutions Limited | A pharmaceutical composition comprising polyaphron dispersion |
CN108530939A (en) * | 2018-04-18 | 2018-09-14 | 济南大学 | A kind of foam spray drying method prepares Determination of Astaxanthin in Haematococcus Pluvialis microcapsules and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
JP4733387B2 (en) | 2011-07-27 |
GB0214793D0 (en) | 2002-08-07 |
US8034325B2 (en) | 2011-10-11 |
EP1515682A1 (en) | 2005-03-23 |
AU2003236910B2 (en) | 2009-07-02 |
CN1703186A (en) | 2005-11-30 |
DE60308519T2 (en) | 2007-04-05 |
AU2003236910A1 (en) | 2004-01-19 |
DE60308519D1 (en) | 2006-11-02 |
US20050238676A1 (en) | 2005-10-27 |
EP1515682B1 (en) | 2006-09-20 |
JP2005536483A (en) | 2005-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1515682B1 (en) | Biliquid foam entrapment | |
US4976961A (en) | Encapsulated cosmetic materials and process of making | |
US4777089A (en) | Microcapsule containing hydrous composition | |
KR970011344B1 (en) | Coated perfume particles in fabric softener or antistatic agents | |
CA2589701C (en) | Microencapsulation product and process | |
EP1337323B1 (en) | Particles | |
US20140364352A1 (en) | Material Release System | |
JP2764143B2 (en) | Composition encapsulating adjuvant with antiperspirant and encapsulation method | |
US20040247664A1 (en) | Gel capsules containing active ingredients and use thereof | |
JP3581830B2 (en) | Surface coating | |
EP0254447A2 (en) | Process for producing polymer-thickened oil macrocapsules | |
EP1343581A2 (en) | Instant water dissolvable encapsulate and process | |
US20030059473A1 (en) | Method for preparing colloidal particles in the form of nanocapsules | |
JP5175436B2 (en) | Emulsion and production method thereof | |
WO1995017954A1 (en) | Process for producing microcapsule of hydrophobic drug | |
JPS6265741A (en) | Cosmetic composition, release of vaporable compound thereof is continued | |
JP2000159661A (en) | Sustained release microcapsule-containing aqueous composition | |
US20240100212A1 (en) | Reversibly protected colorants and methods of use | |
JPS61263633A (en) | Water soluble dry capsule | |
JP2007514686A (en) | Multi-phase active ingredient formulation | |
JPH1147579A (en) | Preparation of solvent-free oil-in-water type emulsion | |
JP3489033B2 (en) | Microcapsule and method for producing the same | |
JPS6354310A (en) | Microcapsule of encapsulated oil useful for cosmetics containing polymer-tackified oily microcapsule |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10517208 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003236910 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003735830 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038148374 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004516925 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003735830 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2003735830 Country of ref document: EP |